AISF position paper on HCV in immunocompromised patients: Digestive and Liver Disease

Italian Association for the Study of the Liver (AISF)

doi:10.1016/j.dld.2018.09.022

AISF position paper on HCV in immunocompromised patients: Digestive and Liver Disease

Italian Association for the Study of the Liver (AISF)

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	10-23
Number of pages	14
Journal	Dig. Liver Dis.
Volume	51
Issue number	1
DOIs	https://doi.org/10.1016/j.dld.2018.09.022
Publication status	Published - 2019

Keywords

HCV
Immunocompromised patients
Organ transplant
antivirus agent
antiviral therapy
Article
clinical feature
heart transplantation
hematopoietic stem cell transplantation
hepatitis C
human
immunocompromised patient
immunopathogenesis
liver transplantation
lung transplantation
mixed infection
nonhuman
oncology
pancreas transplantation
prevalence
priority journal
virology
virus reactivation
chronic hepatitis C
comorbidity
complication
consensus development
graft recipient
immunocompetence
Italy
neoplasm
Antiviral Agents
Comorbidity
Hepatitis C, Chronic
Humans
Immunocompetence
Immunocompromised Host
Neoplasms
Transplant Recipients

Access to Document

10.1016/j.dld.2018.09.022

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055187232&doi=10.1016%2fj.dld.2018.09.022&partnerID=40&md5=01488a98c3e403bb7e29dc8170c2cbc3

Cite this

Italian Association for the Study of the Liver (AISF) (2019). AISF position paper on HCV in immunocompromised patients: Digestive and Liver Disease. Dig. Liver Dis., 51(1), 10-23. https://doi.org/10.1016/j.dld.2018.09.022

@article{5f0038bdb141433a98bcbbd3ccaa793b,

title = "AISF position paper on HCV in immunocompromised patients: Digestive and Liver Disease",

keywords = "HCV, Immunocompromised patients, Organ transplant, antivirus agent, antiviral therapy, Article, clinical feature, heart transplantation, hematopoietic stem cell transplantation, hepatitis C, human, immunocompromised patient, immunopathogenesis, liver transplantation, lung transplantation, mixed infection, nonhuman, oncology, pancreas transplantation, prevalence, priority journal, virology, virus reactivation, chronic hepatitis C, comorbidity, complication, consensus development, graft recipient, immunocompetence, Italy, neoplasm, Antiviral Agents, Comorbidity, Hepatitis C, Chronic, Humans, Immunocompetence, Immunocompromised Host, Neoplasms, Transplant Recipients",

author = "{Italian Association for the Study of the Liver (AISF)} and E. Angelucci and M. Astegiano and C. Baratelli and L. Biancone and P. Bironzo and G. Brancaccio and M.R. Brunetto and R. Bruno and P. Burra and M.G. Cabras and P. Caraceni and C. Chial{\`a} and M.G. Clemente and A. Colli and B. Daniele and {De Gasperi}, E. and {Di Marco}, V. and M.C. Ditto and S. Fagiuoli and C. Ferri and G.B. Gaeta and P.A. Grossi and B. Imperatrice and P. Lampertico and F.S. Macaluso and S. Madonia and M. Marignani and C. Mazzarelli and A. Mella and G. Missale and S. Parisi and L. Pasulo and M. Puoti and M. Rendina and D. Ribaldone and G. Rossi and P. Toniutto and A. Tucci and M. Vigan{\`o} and R. Volpes and E.G. Giannini and L. Miele and F.P. Russo and D. Curci and {Di Maio}, M. and A. Orlando and M. Rizzetto and G. Torre and R. Tozzi",

note = "Cited By :1 Export Date: 12 February 2020 CODEN: DLDIF",

year = "2019",

doi = "10.1016/j.dld.2018.09.022",

language = "English",

volume = "51",

pages = "10--23",

journal = "Dig. Liver Dis.",

issn = "1590-8658",

publisher = "Elsevier B.V.",

number = "1",

}

TY - JOUR

T1 - AISF position paper on HCV in immunocompromised patients

T2 - Digestive and Liver Disease

AU - Italian Association for the Study of the Liver (AISF)

AU - Angelucci, E.

AU - Astegiano, M.

AU - Baratelli, C.

AU - Biancone, L.

AU - Bironzo, P.

AU - Brancaccio, G.

AU - Brunetto, M.R.

AU - Bruno, R.

AU - Burra, P.

AU - Cabras, M.G.

AU - Caraceni, P.

AU - Chialà, C.

AU - Clemente, M.G.

AU - Colli, A.

AU - Daniele, B.

AU - De Gasperi, E.

AU - Di Marco, V.

AU - Ditto, M.C.

AU - Fagiuoli, S.

AU - Ferri, C.

AU - Gaeta, G.B.

AU - Grossi, P.A.

AU - Imperatrice, B.

AU - Lampertico, P.

AU - Macaluso, F.S.

AU - Madonia, S.

AU - Marignani, M.

AU - Mazzarelli, C.

AU - Mella, A.

AU - Missale, G.

AU - Parisi, S.

AU - Pasulo, L.

AU - Puoti, M.

AU - Rendina, M.

AU - Ribaldone, D.

AU - Rossi, G.

AU - Toniutto, P.

AU - Tucci, A.

AU - Viganò, M.

AU - Volpes, R.

AU - Giannini, E.G.

AU - Miele, L.

AU - Russo, F.P.

AU - Curci, D.

AU - Di Maio, M.

AU - Orlando, A.

AU - Rizzetto, M.

AU - Torre, G.

AU - Tozzi, R.

N1 - Cited By :1 Export Date: 12 February 2020 CODEN: DLDIF

PY - 2019

Y1 - 2019

KW - HCV

KW - Immunocompromised patients

KW - Organ transplant

KW - antivirus agent

KW - antiviral therapy

KW - Article

KW - clinical feature

KW - heart transplantation

KW - hematopoietic stem cell transplantation

KW - hepatitis C

KW - human

KW - immunocompromised patient

KW - immunopathogenesis

KW - liver transplantation

KW - lung transplantation

KW - mixed infection

KW - nonhuman

KW - oncology

KW - pancreas transplantation

KW - prevalence

KW - priority journal

KW - virology

KW - virus reactivation

KW - chronic hepatitis C

KW - comorbidity

KW - complication

KW - consensus development

KW - graft recipient

KW - immunocompetence

KW - Italy

KW - neoplasm

KW - Antiviral Agents

KW - Comorbidity

KW - Hepatitis C, Chronic

KW - Humans

KW - Immunocompetence

KW - Immunocompromised Host

KW - Neoplasms

KW - Transplant Recipients

U2 - 10.1016/j.dld.2018.09.022

DO - 10.1016/j.dld.2018.09.022

M3 - Article

VL - 51

SP - 10

EP - 23

JO - Dig. Liver Dis.

JF - Dig. Liver Dis.

SN - 1590-8658

IS - 1

ER -